The most common retatrutide side effects reported in trials are gastrointestinal — nausea, diarrhea, vomiting and constipation. They are usually mild to moderate, tend to appear soon after starting or after a dose increase, and typically ease as the body adjusts. Higher doses caused more of them, which is why the trial raised the dose slowly.
Below: what the phase-2 data actually showed, how strong the effects are by dose, what happens when you stop, and straight answers to the questions people ask most.
Retatrutide is investigational and not FDA-approved for human use. This page summarizes published clinical-trial safety data for information only — it is not medical advice. Always consult a licensed clinician about any GLP-1 therapy. See our Affiliate Disclosure.
The side-effect profile is mostly digestive
In the phase-2 trial published in the New England Journal of Medicine (2023), the side effects that stood out were gastrointestinal. Nausea was the most frequently reported, followed by diarrhea, vomiting and constipation. This is consistent with the wider GLP-1 class — these medicines slow stomach emptying and reduce appetite, and the digestive system feels that first.
Most events were rated mild to moderate. The pattern was clearly dose-dependent: people in the higher-dose groups reported more GI effects than those on lower doses.
Common vs. less common effects
| Frequency | Reported effects |
|---|---|
| Most common | Nausea, diarrhea, vomiting, constipation |
| Also reported | Reduced appetite, indigestion, a modest rise in heart rate |
| Monitored in-study | Cardiovascular measures and metabolic markers, tracked under supervision |
A small increase in heart rate has been observed across GLP-1/GIP/glucagon agents and is one reason these drugs are studied under clinical monitoring rather than used casually.
Do side effects happen right away — and what should you expect?
Yes — GI side effects tend to be strongest early and right after each dose increase, then settle. That timing is exactly why the trial titrated the dose upward slowly instead of starting high.
When they start
Usually within the first days of starting or stepping up a dose, easing over the following weeks as tolerance builds.
What organs are involved
Mainly the digestive tract (nausea, bowel changes). A mild heart-rate increase has also been noted, so cardiovascular signs are monitored in studies.
What happens if you stop
Like other GLP-1 medicines, appetite suppression fades after stopping, and without other changes, some regain of lost weight is common — a pattern seen across the drug class.
Prefer a GLP-1 with a known safety record and real supervision?
Approved options like semaglutide and tirzepatide come with clinician monitoring and a regulated supply chain. Compare the top vetted providers.
Retatrutide side effects: frequently asked questions
What happens when you stop retatrutide?
What are the dangers of retatrutide?
Do retatrutide side effects happen right away?
What organ does retatrutide affect?
Is retatrutide safe?
How does it compare to tirzepatide?
Weight-loss results, mechanism and availability, side by side.
Editor’s picks from our full vendor review. We may earn a commission — it never changes your price.
-
#1
ZevayStreamlined GLP-1 telehealth
Visit site -
#2
ReadyRxFast approvals on weight-loss meds
Visit site -
#3
TrimRxPersonalized programs, US pharmacies
Visit site